Results 181 to 190 of about 4,040 (201)

Meropenem – Vaborbactam

2022
Michelle C. Simpson, Eric G. Schaefer
openaire   +1 more source

Gentamicin/meropenem/vaborbactam

Reactions Weekly, 2021
openaire   +1 more source

Meropenem/vaborbactam

Reactions Weekly, 2020
openaire   +1 more source

Meropenem/vaborbactam cost effective in Italy

PharmacoEconomics & Outcomes News, 2021
openaire   +1 more source

Meropenem-Vaborbactam (Vabomere™): Another Option for Carbapenem-Resistant Enterobacteriaceae.

P & T : a peer-reviewed journal for formulary management
Meropenem-Vaborbactam (Vabomere) for carbapenem-resistant Enterobacteriaceae.
Yuman, Lee, Juliette, Kim, Saralinh, Trinh   +2 more
openaire   +1 more source

Immune-globulin/meropenem/vaborbactam

Reactions Weekly, 2020
openaire   +1 more source

Avibactam/ceftazidime/colistin/meropenem/vaborbactam

Reactions Weekly, 2020
openaire   +1 more source

Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections

Clinical Infectious Diseases, 2020
Ryan K Shields, Erin K Mccreary, Liang Chen   +2 more
exaly  

Meropenem/vaborbactam

Reactions Weekly
openaire   +2 more sources

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Mariana Castanheira, Michael D Huband
exaly